Nonsurgical management of infection-related renal calculi (Q33786334)

29 July 2017

1 reference

title

Nonsurgical management of infection-related renal calculi (English)

1 reference

29 July 2017

Schwartz BF

1

1 reference

PubMed ID

10584617

29 July 2017

Stoller ML

series ordinal

2

1 reference

29 July 2017

1 November 1999

1 reference

Urologic Clinics of North America

29 July 2017

1 reference

29 July 2017

26

1 reference

29 July 2017

4

1 reference

29 July 2017

765-78, viii

1 reference

The fate of residual fragments after extracorporeal shock wave lithotripsy monotherapy of infection stones

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

The Case for a More Aggressive Approach to Staghorn Stones

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Urinary calcium, magnesium, crystals and stones in paraplegia

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

The effect of oral acetohydroxamic acid on urinary saturation in stone-forming spinal cord patients

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Hydroxyurea in the management of chronic urea-splitting urinary infections

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Renal calculosis of patients with traumatic cord lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Nephrocolic fistula in association with a staghorn calculus discovered intraoperatively

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

The risk of renal calculi in spinal cord injury patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Staghorn calculi of the kidney: classification and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

The pathogenesis of urinary tract calculi occurring after ileal conduit diversion. I. Clinical study. II. Conduit study. 3. Prevention.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Unique ability of the Proteus mirabilis capsule to enhance mineral growth in infectious urinary calculi

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Spontaneous dissolution of renal calculi

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Mineralogical studies of urine: the relationship of apatite, brushite and struvite to urinary pH

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

The solubility of struvite in urine

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Bacteriology of branched renal calculi and accompanying urinary tract infection

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Geriatric urolithiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

1 reference

7 January 2021

The severity of infection stones compared to other stones in the upper urinary tract.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

1 reference

7 January 2021

Randomized, Double-Blind Trial of Lithostat™ (Acetohydroxamic Acid) in the Palliative Treatment of Infection-Induced Urinary Calculi

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

A randomized trial of acetohydroxamic acid for the treatment and prevention of infection-induced urinary stones in spinal cord injury patients

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Adjunctive chemotherapy of infection-induced staghorn calculi

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

PICA/burden: a staging system for upper tract urinary stones

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Infection-induced urinary calculi and renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Effects of serum, albumin and immunoglobulins on urease-induced crystallization in urine

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Chronic pyelonephritis as a cause of end stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Applicability of biosuppressin as an urease-inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Nanobacteria: an alternative mechanism for pathogenic intra- and extracellular calcification and stone formation

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Specific inhibition of urease by hydroxamic acids

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Effect of acyl residues of hydroxamic acids on urease inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Specific inhibition of urease by N-acylphosphoric triamides

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Staghorn calculi--long-term results of management

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Formation of staghorn calculi and their surgical implications in paraplegics and tetraplegics

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Ascorbic acid and methenamine mandelate on the urinary pH of spinal cord injury patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

The Prevention of Renal Phosphatic Calculi in the Presence of Infection by the Shorr Regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Potential contribution of optional urease-positive bacteria to idiopathic urinary calcium stone formation. II. Microlith formation kinetics in a fermenter model of the urinary tract infected by optional urease-positive microorganisms

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Metabolic evaluation of infected renal lithiasis: clinical relevance

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Evidence for a Phosphorus-Depletion Syndrome in Man

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Complete longitudinal nephrolithotomy and the Shorr regimen in the management of staghorn calculi

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Urease inhibitor therapy in infected renal stones

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Spontaneous disappearance of a staghorn calculus

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Influence of chondroitin sulfate, heparin sulfate, and citrate on Proteus mirabilis-induced struvite crystallization in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Pyrophosphate inhibition of Proteus mirabilis-induced struvite crystallization in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Proteus mirabilis biofilm protection against struvite crystal dissolution and its implications in struvite urolithiasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Results of surgical and conservative therapy on patients with nephrolithiasis and chronic renal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Flurofamide: a potent inhibitor of bacterial urease with potential clinical utility in the treatment of infection induced urinary stones

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Ascorbic acid as a urinary acidifying agent. 1. Comparison with the ketogenic effect of fasting.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Ascorbic acid as a urinary acidifying agent. 2. Its adjunctive role in chronic urinary infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Medical dissolution of canine struvite uroliths

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Crystalline composition of urinary stones in Norwegian patients

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Effect of ammonium on bacterial adherence to bladder transitional epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Effect of chronic administration of ammonium sulfate on phosphatic stone recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Branched renal calculi

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

The mechanism of ammonia excretion during ammonium chloride acidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Glycosaminoglycans content of stone matrix.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Surgical classification of renal calculi

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Retrospective study of 95 patients with staghorn calculus disease

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Gastropyeloplasty: a swine model

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Nephrolithiasis Clinical Guidelines Panel summary report on the management of staghorn calculi. The American Urological Association Nephrolithiasis Clinical Guidelines Panel

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Aluminum gels in the management of renal phosphatic calculi

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Constituents of Urinary Calculi containing Struvite

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Treatment of infected urinary stones in rats by a new hydroxamic acid, "N-(pivaloyl)glycinohydroxamic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Scanning electron microscopy detects bacteria within infection stones

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Long-term renal fate and prognosis after staghorn calculus management

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Experimental urolithiasis. III. Prevention and dissolution of calculi by alteration of urinary pH

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

Citrate and urease-induced crystallization in synthetic and human urine

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

A randomized double-blind study of acetohydroxamic acid in struvite nephrolithiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970217-2

7 January 2021

10.1016/S0094-0143(05)70217-2

Identifiers

DOI

1 reference

release_enweo6vfjzcibk26jo4w7cffue

29 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/enweo6vfjzcibk26jo4w7cffue

24 November 2022

mapped directly with Wikidata item

PubMed ID

10584617

1 reference

PubMed ID

10584617